Heron Therapeutics, Inc. (HRTX) vs Xilio Therapeutics, Inc. (XLO)
Heron Therapeutics, Inc. and Xilio Therapeutics, Inc. are both Biotechnology companies. Heron Therapeutics, Inc. and Xilio Therapeutics, Inc. are of similar size ($59.2M and $57.0M). Xilio Therapeutics, Inc. grew revenue faster over the last twelve months: 327.3% against 0.99%. Heron Therapeutics, Inc. has the higher net margin (−22.5% vs −34.1%) and the lower return on invested capital (−6.35% vs 0.00%). Across the 17 metrics below, Xilio Therapeutics, Inc. leads on 9 and Heron Therapeutics, Inc. on 8.
Valuation
Profitability
| Metric | HRTX | XLO | Biotechnology median |
|---|---|---|---|
| Gross margin | 70.07% | 100.00% | 65.16% |
| Operating margin | (7.19%) | (48.94%) | 0.00% |
| Net margin | (22.52%) | (34.06%) | 0.00% |
| Free cash flow margin | (8.00%) | (95.59%) | 0.00% |
| Return on equity | 318.21% | (55.03%) | (57.72%) |
| Return on assets | (14.06%) | (15.16%) | (49.22%) |
| Return on invested capital | (6.35%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack